Can I read Immune Checkpoint Inhibitors for EGFR-NSCLC on EtoBox?

Immune Checkpoint Inhibitors for EGFR-NSCLC by Doctor Wang is a document available to read on EtoBox.

What is Immune Checkpoint Inhibitors for EGFR-NSCLC about?

This systematic review and meta-analysis evaluated the efficacy and safety of immune checkpoint inhibitors (ICIs) for individuals with advanced EGFR-mutated non-small-cell lung cancer (NSCLC) who progressed on EGFR tyrosine-kinase inhibitors (TKIs). The findings indicated that the combination of ICI with antiangiogenic therapy and chemotherapy (ICI-antiangio-chemo) provided the best progression-free survival outcomes, although it was associated with higher toxicity compared to other treatments. Overall, the

Author

Doctor Wang

Language

EN